Bone marrow transplantation for treatment of leukemia in children (Q39523019)

12 September 2017

1 reference

title

Bone marrow transplantation for treatment of leukemia in children (English)

1 reference

12 September 2017

Trigg ME

1

1 reference

12 September 2017

publication date

1 August 1988

1 reference

Pediatric Clinics of North America

12 September 2017

published in

1 reference

12 September 2017

volume

35

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

933-948

1 reference

Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985. A report from the Childrens Cancer Study Group

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Which treatment for childhood acute lymphoblastic leukaemia in second remission?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Graft rejection and graft-versus-host disease: mirror images

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

The use of partially matched, unrelated donors in clinical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Treatment of acute myelogenous leukemia in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936516-6

7 January 2021

10.1016/S0031-3955(16)36516-6

Identifiers

DOI

0 references

1 reference